PPI in walnut allergy

Phase 1

• Conditions: walnut allergic patients; MedDRA version: 18.0Level: PTClassification code 10016946Term: Food allergySystem Organ Class: 10021428 - Immune system disorders; Therapeutic area: Diseases [C] - Immune System Diseases [C20]

• Registration Number: EUCTR2015-001863-38-ES
• Lead Sponsor: Fundación para la investigación biomedica del hospital clinico san carlos de madrid

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-07-31
• Last Update Posted: 23 July 2018

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

- positive case history of allergic reaction(s) to walnut
- age ? 18 years
- cutaneous reaction positive to walnut
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 27
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 3

Exclusion Criteria

- intake of drugs interfering with Omeprazole or the allergic response under food challenge
- pregnancy, breastfeeding
- acute allergic disease
- epinefrine contraindication

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified